Stay updated on Etrasimod in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.

Latest updates to the Etrasimod in Ulcerative Colitis Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision metadata was updated from v3.5.4 to v3.5.5. This reflects a minor behind-the-scenes update to the page template or CMS, with no changes to study content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study document revision label was updated from v3.5.3 to v3.5.4, indicating an updated version of the protocol-related materials.SummaryDifference0.0%

- Check43 days agoChange Detected- Updates the citation entry for a specific PubMed-derived publication about non-serious adverse events in ulcerative colitis patients receiving etrasimod. - Updates the ClinicalTrials.gov page revision/build label from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check115 days agoChange DetectedThe changes consist of a minor revision update (Revision: v3.4.2 added; Revision: v3.4.1 deleted) with no visible impact on study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Etrasimod in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.